Medical doctors of different specialties use SCENAR therapy in their practice. Doctoral and master's theses were presented, a database on the positive effects of SCENAR treatment has been created, many physiological studies and clinical investigations have been carried out.

Here is what famous SCENAR therapists say: 

Yury Gorfinkel MD. (Taganrog, Russia)	Alex Eingorn DC, FABDA, (New York, USA)	Shmuel Tatz PT, Ph.D. (New York, USA)	Katie Noonan (Mexico, Mexican)	Iveta Iontcheva-Barehmi DMD, MS (Boston, USA)
Dr. Alexander Tarakanov MD, PhD, Professor (Russia)	Dr. Iosif Semikatov MD (Yekaterinburg, Russia)	Dr. Vladimir Lopatko MD (Nizhny Tagil, Russia)	Dr. Irina Ershova MD (Moscow, Russia)	Boris Kulizhskiy (Rostov-on-Don, Russia)
Dr. Natalia Nikushina MD (Taganrog, Russia)	Dr. Constantin Nikitin MD (Tomsk, Russia)	Dr. Monique Latar MD (France)	Dr. Jörg Prinz MD (New Zealand)	Dr. Andreas Maar (Germany)
Dr. Carlos Udina MD (Spain)

SCENAR - an abbreviation of the full name of a medical devices class. It is short for a self-controlled energyneuroadaptive regulator. Or, briefly, energyneurostimulator.

SCENAR devices have an advantage over the standard electrostimulators which use a permanent electrical impulse. So the body habituates to it quickly and ceases responding. When you take an ice cube, you first feel cold, and then the feeling gets much weaker. In the same way the body responds to a permanent electrical impulse. Engineers of RITM OKB ZAO decided to substantially increase the efficiency of our devices. So they made the device impulse alternate and neural, i.e. very similar to the pulses transmitted by the human nervous system.

The effect surpassed all expectations! The test results were so unexpected and effective, that a lot of enthusiasts and followers appeared both among medical professionals and patients. SCENAR therapy became a new trend in medicine. It has aroused heightened interest in the West. As a result this type of device has been licensed and certified in many countries. Now SCENAR is recognized and became widely used by medical professionals all over the world.

However, in order to achieve high performance in the treatment of acute and chronic pain-related conditions with help of SCENAR, it is recommended to receive relevant training.

SCENAR treatment range

In the Russian Federation SCENAR is registered and clinically proved its efficiency in treatment of various disorders. However, in the most other counrties it is certified by regulatory authorities as a device for pain relief.

INDICATIONS WITH REGARD TO PAIN RELATED TO:

SCENAR devices are indicated to be used in professional medicine and at home in the following cases:

• to analgesic therapies in pains in bones, muscles, joints and ligaments;
• to manage acute and chronic back pain;
• to treat primary dysmenorrhea;
• for procedural pain management after timed endometrial biopsy;
• to alleviate attacks and for course treatment of trigeminal neuralgia;
• to relieve pain in diabetic neuropathy (diabetic foot);
• to relieve pain in postherpetic neuralgia concurrently with antiviral drug therapy;
• for pain relief in chronic/recurrent headaches and tension-related headaches.

Only in professional medicine SCENAR devices are indicated to be used:

• For postoperative analgesia:

1. in traumatology and orthopedics after surgical treatment of ankle fracture, femur fracture including hip replacement with an implant, knee replacement with an implant, after shoulder surgery;
2. after abdominal surgeries in inguinal hernia and laparoscopic cholecystectomy;
3. in urology after extracorporeal shock wave lithotripsy.

•  In dentistry in comprehensive treatment of traumatic fractures of the mandible to provide analgesia, to alleviate symptoms and reduce treatment duration.
• To manage acute pelvic pain in women.
• To manage acute pain in renal colic.
• To relieve pain after cesarean section and after hysterectomy.

RITM OKB ZAO developed special techniques to achieve better results of treatment using SCENAR along with other products of our company. For example, experienced SCENAR therapists prefer to combine SCENAR treatment sessions with the use of ULM healing blanket.

SCENAR (or, more precisely, its prototype) was created in OKB in the late 1970s. The first devices were called ENS-01 (EnergoNeuroadaptive Stimulator, first model). In terms of beta-testing, ENS-01 devices were used by the medical doctors in Taganrog, Krasnodar, and Sochi. The feedback was different but that was the first time when particular outcomes which were not expected by medical doctors were received (today we call them SCENAR effects). The device was improved and upgraded by the combined effort of medical doctors and engineers of RITM OKB (A. Karasyov, A. Revenko, S. Sliva, Y. Gorfinkel, A. Kyberev, V. Zakharevich). A special part in the expertise was taken by Alexander Nechushkin, Head of Laboratory of Bioenergetics and Reflexotherapy at Central Institute of Traumatology and Ortopaedics (Moscow), former President of USSR Association of Reflexotherapists, later on Director of Institute of Reflexotherapy and one of the experts of Comission of Ministry of Health of the USSR (Russian Federation); Arseny Medelyanovskiy, Head of Laboratory of Systemic Homeostasis at Institute of Normal Physiology anmed after P.K. Antokhin, expert of the Comission of Ministry of Health of the USSR (Russian Federation), medical supply expert of the Army Forces.

In 1986 first SCENAR devices were presented to the Ministry of Health of the USSR. The first certificate of authorship of “Electrostimulator” was received in 1987 (V. Zakharevich, A. Hechushkin, A. Karasyov, A. Revenko, A. Kibyrev), second – “Electrostimulation device” – in 1989 (A. Karasyov, V. Zakharevich, A. Revenko, A. Kibyrev, A. Dygai).

The SCENAR test results were fairly impressive. Successful treatment experience attracted a lot of enthusiasts and followers of this method of treatment both among patients and medical professionals. This treatment method even received its own name – SCENAR therapy. In late 1980s SCENAR therapy received its first active followers among medical professionals in different areas: Y. Gorfinkel, P. Kruglov, L. Pak, S. Pobokin, A. Dogadkin, V. Leontyev, S. Nikolayev, S. Posvezhinsky. Their observations received on practice strengthen the assurance in the chosen direction.

In 1989 RITM OKB registers a trademark “SCENAR”. Research and development are oriented on the serial production. SCENAR-033, SCENAR-033M, and other device models were created. In the early 1990s, the serial production of SCENAR-035-1 and SCENAR-035-3 devices was finally launched.

Since that time RITM OKB ZAO keeps developing and upgrading SCENAR devices. Several SCENAR generations changed one another. See the chronology of SCENARs represented below.

SCENAR’s success resulted in many imitations – devices with similar characteristics manufactured by other companies occurred later on. However, the priority and leading positions in developing of SCENAR device and advanced development are still held by RITM OKB ZAO.

Who was actually the first?

Recently a lot of false information about who created SCENAR and where it was created appeared on the Internet. Numerous authors of the publications, claiming on the priority in SCENAR development do not trouble themselves neither with publishing documents which could prove their claims, nor with corresponding to the real facts of the past.

In contrast, everything that we say can be confirmed by documents, which are kept in RITM OKB ZAO, and by numerous witnesses.

The first certificate of authorship № 1817335 for “Electrical stimulator” on request № 4171898 with priority on January 4, 1987 was acquired by the V.D. Kalmykov Taganrog radioengineering institute on October 11, 1992 (see photo 1). The authors are Vladislav Zakharevich, Alexander Nechushkin, Alexander Karasev, Alexander Revenko and Alexander Kibirev. On April 23, 1993 the certificate, issued in the USSR has expired. Instead Patent № 1817335 appeared on the same day (it must be noted that it is a patent now, not a certificate of authorship, photo 2), issued by Rospatent. The patent was published on August 27, 1995. Before that day it was marked as “for official purposes”. The patenting (filling of application for an invention) was conducted by the institute because RITM OKB did not have such specialists on the staff (at that time we were called RITM OKB under the V.D. Kalmykov Taganrog radioengineering institute). Each of the five authors had 20% without any priority.

On December 12, 1986, an agreement № 142254 was completed with a company P.O.box G-4897 (see photo 3) to commercialize the devices. That was the time when the word “SCENAR” appeared in documentation issued by RITM OKB. By the end of 1987 development of experimental models SCENAR-033, SCENAR-032, SCENAR-031 was finished at OKB (see photos 4,5). For your reference: SCENAR-031 was sent to the Ministry of Health for testing and after its completion the same device got the name SCENAR-035 as SCENAR-033 and SCENAR-032 had already been tested at the Ministry of Health. The first testing of ENS 03 devices were held at the N.N. Priorov Central Institute of Traumatology and Orthopaedics (CITO) and at the P.K. Anokhin Research Institute of Normal Physiology in 1986 and affirmed by Shapochnikov Y.G. and Sudakov K.V, directors of CITO and research institute. Both of them are world-famous scientists.

The first device in the SCENAR family that passed all technical and clinical testing and was approved by the Ministry of Health of the USSR in 1990 was SCENAR-033 (photo 6).

Thus, the first certificate of authorship, the first patent, the first testing of the devices at the leading research institutes of the USSR, the first approval from the Ministry of Health of the USSR was received by us.